Edition:
United States

Lotus Pharmaceutical Co Ltd (1795.TWO)

1795.TWO on Gre Tai Securities Market of Chinese Taipei

53.00TWD
21 Apr 2017
Change (% chg)

NT$-0.30 (-0.56%)
Prev Close
NT$53.30
Open
NT$54.50
Day's High
NT$54.50
Day's Low
NT$53.00
Volume
326
Avg. Vol
1,343,510
52-wk High
NT$70.10
52-wk Low
NT$45.50

Latest Key Developments (Source: Significant Developments)

Alvogen Korea to buy back shares at 50 bln won
Friday, 7 Apr 2017 05:35am EDT 

Alvogen Korea Co Ltd <002250.KS> : Says it will repurchase 1.7 million common shares . Says repurchase amount is 50 billion won .Says repurchase period from April 10 to May 2.  Full Article

Lotus Pharmaceutical got U.S FDA approval for Calcium Acetate Capsule 667mg
Wednesday, 27 Jul 2016 06:15am EDT 

Lotus Pharmaceutical <1795.TWO>:Says it got U.S FDA approval for its generic drug Calcium Acetate Capsule 667mg.  Full Article

Lotus Pharmaceutical gets FDA approval for Levetiracetam ER Tablets
Monday, 13 Jun 2016 06:00am EDT 

Lotus Pharmaceutical <1795.TWO>:Says it got FDA approval for its generics drug Levetiracetam ER Tablets.  Full Article

Lotus Pharmaceutical gets U.S FDA approval for Temozolomide Capsules
Thursday, 28 Apr 2016 04:37am EDT 

Lotus Pharmaceutical Co Ltd:Got U.S FDA approval for its generic medicine Temozolomide Capsules 5mg, 20mg, 100mg, 140mg, 180mg and 250mg.  Full Article

Lotus Pharmaceutical announces no dividend payment for 2015
Wednesday, 16 Mar 2016 11:18am EDT 

Lotus Pharmaceutical Co Ltd:To pay no dividend to shareholders for 2015.  Full Article

Lotus Pharmaceutical receives FDA final approval for generic drug Paricalcitol Capsules
Thursday, 25 Feb 2016 10:24am EST 

Lotus Pharmaceutical Co Ltd:Received U.S FDA final approval for generic drug Paricalcitol Capsules.  Full Article

Lotus Pharmaceutical announces change of CEO and general manager
Wednesday, 13 Jan 2016 07:47am EST 

Lotus Pharmaceutical Co Ltd:Appoints Siegfried Gschliesser as new CEO and general manager to succeed Renaat Janssen, effective Jan. 20.  Full Article

Lotus Pharmaceutical announces exclusive distribution agreement of subsidiary
Friday, 2 Oct 2015 07:33am EDT 

Lotus Pharmaceutical Co Ltd:Says subsidiary Alvogen Korea signed an agreement with AstraZeneca Korea, regarding exclusive distribution of Seroquel that a mental illness treatment in Korea market.Alvogen Korea to hold rights of marketing, sales and agents that product in Korea market.Effective Oct. 1.  Full Article

Lotus Pharmaceutical receives tentative approval for Paricalcitol Capsules from U.S FDA
Friday, 24 Jul 2015 05:01am EDT 

Lotus Pharmaceutical Co Ltd:Received tentative approval for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg from U.S Food and Drug Administration.  Full Article

Lotus Pharmaceutical to change general manager
Wednesday, 24 Jun 2015 07:30pm EDT 

Lotus Pharmaceutical Co Ltd:To change general manager to Renaat Janssen from Gschliesser Siegfried, effective Aug. 1.  Full Article

More From Around the Web